Are you Dr. Butler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Medical Plaza
365
Los Angeles, CA 90095Phone+1 310-825-7922
Summary
- Dr. Peter Butler, MD is an endocrinologist in Los Angeles, California. He is currently licensed to practice medicine in California, Minnesota, and North Carolina. He is affiliated with Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1993
- Freeman Health System1982 - 1984
- Birmingham University Medical SchoolClass of 1980
Certifications & Licensure
- CA State Medical License 2000 - 2025
- MN State Medical License 1993 - 2002
- NC State Medical License 1990 - 1992
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Subcellular Compartmentalization of Glucose Mediated Insulin Secretion.Zhongying Wang, Tatyana Gurlo, Leslie S Satin, Scott E Fraser, Peter C Butler
Cells. 2025-01-29 - Dysregulation of cholesterol homeostasis is an early signal of β-cell proteotoxicity characteristic of type 2 diabetes.Tatyana Gurlo, Ruoshui Liu, Zhongying Wang, Jonathan Hoang, Sergey Ryazantsev
Physiological Genomics. 2024-09-01 - Application of fluorescence lifetime imaging microscopy to monitor glucose metabolism in pancreatic islets.Zhongying Wang, Maani Archang, Tatyana Gurlo, Elaine Wong, Scott E Fraser
Biomedical Optics Express. 2023-08-01
Press Mentions
- ® Announces Latest Institute for Value-Based Medicine® MeetingApril 2nd, 2019
- Type 2 Diabetes Drug May Cause CancerJanuary 29th, 2016
Grant Support
- Capacity And Mechanisms Of Beta Cell Regeneration In HumansNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2012
- Role Of IAPP In Islet Dysfunction In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2012
- Role Of Pulsatile Insulin SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Role Of Pulsatile Insulin Secretion.National Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
- Role Of Pulsatile Insulin Secretion.National Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
- Role Of IAPP In Islet Dysfunction In DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2003
- Restoration Of First Phase Insulin Secretion On Pulsatile Secretion In NIDDMNational Center For Research Resources1996–1997
- Pulsatile Insulin Secretion By Hepatic Transplanted IsletsNational Center For Research Resources1995
- Pulsatile Insulin Secretion On Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1995
- Role Of Pulsatile Insulin Secretion On Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1993
- Isotopes Of Glucose, Leucine, And Palmitate As Irreversible Tracers Of GlucoseNational Center For Research Resources1992